Dextrin.

Resistant dextrin is dextrin processed so its alpha-1,2 and alpha-1,3 links resist pancreatic amylase. Blending the two splits delivery between rapid glucose release and colonic fermentation.

The indigestible fraction of dextrin is fermented by colonic bacteria into short chain fatty acids, butyrate among them. Supplying butyrate directly covers the proximal colon while the dextrin feeds production further along.

Bifidobacteria carry the glycoside hydrolases that open dextrin's alpha linkages, so the fibre acts as a growth substrate for the strain delivered alongside it. Pairing substrate with organism is standard synbiotic practice.

Fermentable dextrin gives an ingested lactobacillus a carbon source on arrival in the large bowel rather than leaving it to compete for whatever the diet provides. Lactate and acetate output rises as a result.

Fermentation of dextrin acidifies the colonic lumen, which holds calcium in its soluble ionised form and supports passive uptake past the small intestine. The effect is modest and depends on how much of the dextrin escapes amylase.

Digestible dextrin releases glucose quickly and the resulting insulin rise stimulates the sodium-dependent creatine transporter in muscle. Long-standing formulation practice is to carry creatine in a rapidly digested carbohydrate.

Chicory inulin and wheat dextrin are fermented by different parts of the colonic community, so a blend spreads substrate across more of the bowel than either alone. A simulated human gut microbiome study of these mixtures reported shifts in community composition and short-chain fatty acid output. The measurements are microbial and in vitro, not clinical endpoints in people.

Both escape small-intestinal digestion and arrive in the colon as fermentable glucose polymers. Resistant starch is granular and ferments more slowly, resistant dextrin is soluble and ferments earlier, so the pair covers a wider stretch of transit. Combining them raises total fermentable load, which is also what drives gas at high intakes.

Short-chain fructans ferment rapidly in the proximal colon while resistant dextrin persists further along. Formulators pair them for that staggering rather than for any tested combination effect. Read it as mechanistic rather than clinical.

Galactooligosaccharides are selectively used by bifidobacteria, and resistant dextrin supports a broader saccharolytic community. Blending gives a wider substrate range at a lower dose of each. No combination trial is cited here.

Both are low-viscosity soluble fibres chosen because they dissolve clear and do not thicken a drink. They are fermented to short-chain fatty acids by overlapping but not identical taxa. The pairing is formulation convention plus additive fermentable load.

Oat beta-glucan is viscous and slows gastric emptying, dextrin is not viscous and contributes fermentable substrate instead. The two properties are separable, so a blend can carry viscosity and fermentability at once. Viscosity is the property that drives the postprandial effect, not the dextrin.

A fermentable substrate gives an ingested strain something to grow on once it reaches the colon. Resistant dextrin is used this way in synbiotic formats. Whether a given strain actually uses it depends on that strain's carbohydrate-utilisation genes, which varies.

Bifidobacteria carry the enzyme sets for breaking down oligosaccharides and dextrin fragments through the bifid shunt. The end products include acetate and lactate, which other species convert onward to butyrate. This is cross-feeding biochemistry rather than a tested product claim.

This species has a wide sugar-utilisation repertoire and ferments short glucose oligomers to lactate. Lactate is then taken up by butyrate producers. The link to any measured human outcome is not established by the rows here.

Dextrins are the direct products of alpha-amylase cutting starch at internal alpha-1,4 bonds. Adding amylase to a starch-containing formula produces more dextrin and eventually maltose. The relationship runs in the other direction too: supplemental amylase shortens dextrins already present.

Brush-border maltase-glucoamylase and sucrase-isomaltase finish the job amylase starts, releasing glucose from alpha-limit dextrins. A digestive enzyme blend containing amylase and glucoamylase covers the same steps in the lumen. Resistant dextrin's altered linkages are precisely what these enzymes cannot cut.

Glucose released from maltodextrin is taken up with sodium through SGLT1, and that co-transport pulls water across the epithelium. This is why carbohydrate-electrolyte drinks pair a dextrin with sodium rather than using sugar alone. The osmolality is lower per unit of glucose delivered because dextrin is a polymer.

Fermentation of resistant dextrin lowers colonic pH, and divalent minerals are more soluble at lower pH. Rodent and human work on fermentable fibres and mineral uptake supports the mechanism generally. Whether it moves magnesium status in a person taking a normal dose is not settled.

The same acidification that helps magnesium applies to zinc, and short-chain fatty acids also support colonocyte turnover. The effect is on solubility in the lumen, a step before absorption, not on zinc status directly. Count it as mechanistic.

Maltodextrin is the usual carbohydrate carrier in a post-training protein drink because it dissolves clear and empties from the stomach quickly. A randomised study of resistance training with carbohydrate and protein supplementation reported changes in insulin-sensitivity and lipid markers, which are markers rather than outcomes. Dextrin's role in that format is the carbohydrate vehicle.

Psyllium forms a gel and is only slightly fermented, so it acts on stool form and transit. Resistant dextrin is barely viscous and is largely fermented. Together they cover both of the things soluble fibre is asked to do, from opposite ends of the fermentability range.